Prognyx oncology intelligence

{'type': 'object', 'required': ['asset', 'indication'], 'properties': {'asset': {'type': 'string', 'maxLength': 80, 'description': 'Public asset or target, e.g. "sotorasib", "KRAS G12C", "B7-H3".'}, 'indication': {'type': 'string', 'maxLength': 80, 'description': 'Oncology indication, e.g. "colorectal cancer", "NSCLC".'}}, 'additionalProperties': False}

{'type': 'object', 'properties': {'limit': {'type': 'integer', 'default': 5, 'maximum': 20, 'minimum': 1, 'description': 'Briefings to return.'}, 'query': {'type': 'string', 'maxLength': 120, 'description': 'Drug, company, target or indication. Empty returns the latest.'}}, 'additionalProperties': False}

{'type': 'object', 'required': ['query'], 'properties': {'limit': {'type': 'integer', 'default': 10, 'maximum': 25, 'minimum': 1, 'description': 'Studies to return.'}, 'query': {'type': 'string', 'maxLength': 160, 'description': 'e.g. "KRAS G12C", "Nuvalent", "claudin 18.2 gastric cancer", "NCT05132075".'}}, 'additionalProperties': False}